Ejaculatory disorders after prostatic artery embolization: A reassessment of two prospective clinical trials
World Journal of Urology Dec 12, 2019
Müllhaupt G, Hechelhammer L, Diener PA, et al. - Case report forms of the randomized controlled trial of people with evaluable ejaculation were examined in order to stipulate and describe the former findings of unexpectedly high rates of ejaculatory disorders, ie, 56%, obtained following prostatic artery embolization (PAE) in a randomized controlled trial contrasting safety and efficiency of PAE and transurethral resection of the prostate (TURP). While people following TURP predominantly experienced anejaculation (52%), reduced ejaculation was discovered more frequently following PAE (40%). Three months following PAE and at a median follow-up of 31 months, significantly greater Male Sexual Health Questionnaire-Ejaculation Dysfunction Short Form scores were obtained. Histological examination explicated marked variations of structures involved in ejaculation following PAE. In conclusion, however, in comparison with TURP (52%), anejaculation occurs less often following PAE (16%), people have to be notified about the appropriate risk of ejaculatory disorders, particularly reduced ejaculation.Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free.
55 lakhs+ doctors trust M3 globally
Unlimited access to original articles by experts
Secure: we never sell your data
Signing up takes less than 2 mins